Aspira Pathlab & Diagnostics Limited (ASPIRA.BO)
BSE · INR · Healthcare · Diagnostics & Research
₹125.00 (-0.40%) as of
Key statistics
- Market cap
- 1.29B
- EPS (TTM)
- -0.45
- Dividend yield
- 0.00%
- 52-week range
- 49.00 – 149.99
- Beta
- 0.48
- Revenue (TTM)
- 259.03M
- Profit margin
- -1.58%
- Volume
- 162.00
About Aspira Pathlab & Diagnostics Limited
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides pathology, sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Mumbai, India
- Employees
- 168
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- NAGREEKA CAP & INFR.LTD (NAGREEKCAP.NS)
- BEST EASTERN HOTELS LTD. (BESTEAST.BO)
- GOLDEN LEGAND LEASING & FINANC (GOLDLEG.BO)
- LIC Mutual Fund (LICNMID100.BO)
- SRI RAMAKRISHNA MILLS (COIMBAT (SRMCL.BO)
- Bajaj Finserv Mutual Fund (BANKBETF.BO)
- Praxis Home Retail Limited (PRAXIS.BO)
- AMARNATH SECURITIES LTD (AMARSEC.BO)